4.4.6.4 Reduction of Toxicity, Mobility, or Volume through Treatment -- Alternative 6 This evaluation criterion addresses the statutory preference for selecting remedial actions that employ treatment technologies that permanently and significantly reduce the toxicity, mobility, or volume of hazardous substances. This preference is satisfied when treatment reduces the principal threats at a site through destruction of toxic contaminants, reduction of the total mass of toxic contaminants, irreversible reduction in contaminant mobility, or reduction of the total volume of contaminated media. The ability of bioremediation to reduce the toxicity or volume of contamination at a site was assessed based on the following considerations: Reduction in toxicity of contaminated material Reduction in mobility of contaminants Reduction in volume of contaminated materials Irreversibility of treatment Each of these considerations is addressed below. Reduction in Toxicity of Contaminated Material This alternative would reduce the toxicity of the contaminants during both the anaerobic and aerobic phases of biological treatment. Anaerobic dechlorination has been observed to occur primarily from the meta and para positions, with corresponding increases in less-chlorinated, ortho-substituted congeners in both naturally-occurring sediments (Brown and others 1987) and in the laboratory (Abramowicz and others 1993; GECRD 1994; and Quensen, Tiedje, and Boyd 1988). The less-chlorinated congeners that result from anaerobic dechlorination are both less toxic and more readily degraded by aerobic bacteria than the initial highly-chlorinated congeners (Quensen, Tiedje, and Boyd 1988; and PRC 1995e). The toxicity of treatment residuals from anaerobic dechlorination would be further reduced during aerobic degradation. Aerobic degradation is a destructive process in which aerobic bacteria ultimately convert PCBs to nontoxic end products including carbon dioxide, water, chloride salts, and cell mass. Reduction in Mobility of Contaminants Bioremediation reduces the mobility of PCBs. Only the resistant fraction of PCBs would remain after biological treatment, and the same mechanisms that cause this resistant fraction to lack bioavailability, such as sorption to organic material, would prevent the PCBs from partitioning into solution and becoming mobile. Reduction in Volume of Contaminated Material This alternative could possibly increase the volume of materials. During CSPB, bulking agents may be added to provide organic substrate and increase the porosity of the material, which would further increase the volume of the material requiring treatment at the CTF. However, depending on the organic content of the contaminated materials, biological treatment could possibly cause a reduction in volume as the biodegradable organic matter is converted to methane and carbon dioxide, which would be released as gases from the materials during anaerobic and aerobic treatment, respectively. Irreversibility of Treatment Anaerobic dechlorination and aerobic destruction are both irreversible processes under the conditions that would be present in the treatment residuals. Dechlorinated PCBs would not recombine with chloride ions, and PCBs would not be reformed by the end products of aerobic PCB destruction.